Synthesis and Reactivity in Inorganic Metal-Organic and Nano-Metal Chemistry · 2005 · 37 citations · 33 references
MedicineOncologyPharmacologyMolecular OncologyRadionuclide TherapyTherapeutic Nuclear MedicineLigand BindingPeptide ChemistryRadiopharmaceutical DesignRadiopharmaceuticalsTargeted RadiopharmaceuticalsTumor Receptor ImagingPeptide ConjugatesPeptide RadiolabelingPeptide RadiopharmaceuticalsPeptide-based RadiopharmaceuticalsPeptide-based RadiotracersRadiochemical SynthesisRadiotracer SynthesisTumor-targeting Peptides
Bombesin (BBN) is a peptide exhibiting high affinity for the gastrin releasing peptide receptor (GRPr), which is over‐expressed on a variety of human tumors including breast, prostate, lung and pancreatic cancers. The specific aim of this study was to identify a new 99mTc‐radiolabeled BBN analogue based upon the bifunctional chelating ligand HYNIC (2‐hydrazinonicotinamide) that might be used as a noninvasive tool for diagnosis of GRP receptor‐positive tumors. In this study, HYNIC‐β‐Ala‐BBN(7‐14)NH2 and HYNIC‐5‐Ava‐BBN(7‐14)NH2 were synthesized using traditional solid phase peptide synthetic techniques. The newly‐formed conjugates were radiolabeled using 99mTc in the presence of different coligands including tricine, ethylenediamine diacetic acid (EDDA), tricine/EDDA, and tricine/nicotinic acid. Radiolabeling conditions (i.e., pH, temperature, and reaction time) were optimized and evaluated by ITLC and reversed‐phase HPLC.
33
Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer
Frank Cuttitta, Desmond N. Carney, James L. Mulshine et al. · Nature · 1985 · 1.4K citations
Medicine, Cancer Biology, Oncology +11
Somatostatin-Receptor Imaging in the Localization of Endocrine Tumors
S.W.J. Lamberts, W. Halsey Barker, J.C. Reubi et al. · New England Journal of Medicine · 1990 · 533 citations · Full text
Medicine, Nuclear Medicine, Oncology +17
Roger Schibli, R. Schwarzbach, Roger Alberto et al. · Bioconjugate Chemistry · 2002 · 182 citations